Search

Filters

Clear Filters
3:20 PM - 3:30 PM PT

132 - Consolidative Radiotherapy with Osimertinib in Advanced EGFR-Mutant Non-Small Cell Lung Cancer: Long-Term Local and Intracranial Control Results from a Phase II Trial
Speaker: Sampath, Sagus, MD - City of Hope Medical Center, Duarte, CA
3:30 PM - 3:40 PM PT

133 - First-Line EGFR-TKIs Combined with Primary-Focus Radiotherapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): A Real-World Retrospective Study
Speaker: Li, Yan, MD - West China Hospital of Sichuan University, Chengdu, Sichuan
2:30 PM - 2:40 PM PT

134 - Interrogating Contributions of the Sensory Neuroimmune Axis to Treatment Resistance in Head and Neck Squamous Cell Carcinoma
Speaker: Idlett-Ali, Shaquia, MD, PhD, BS - University of Colorado School of Medicine, Aurora, CO
2:40 PM - 2:50 PM PT

135 - IL-17-Producing Gd T Cells Recruited By Cgas-Sting-Dependent CCL20 in Macrophages Drive Radioresistance
Speaker: Deng, Yue - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, wuhan
2:50 PM - 3:00 PM PT

136 - E2F1-Fanconi Anemia Complementation Group I (FANCI) Mediates Oncogenic BRAF-Driven Radiation Resistance in Anaplastic Thyroid Cancer
Speaker: Yang, Linlin, MD, PhD - City of Hope Comprehensive Cancer Center, Duarte, CA
3:00 PM - 3:10 PM PT

137 - Exploiting Dependencies Created By KEAP1/NFE2L2 Mutations in NSCLC to Overcome Radiation Resistance
Speaker: Mai, Wilson, MD, PhD - Stanford University Cancer Center, Stanford, CA
3:10 PM - 3:20 PM PT

138 - Radiation-Enhanced CD24 Membrane Trafficking via GPI Anchoring Underlies Immune Evasion after Radiotherapy
Speaker: Kong, Lingyi, MD - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei
3:20 PM - 3:30 PM PT

139 - Genomic and Transcriptomic Profiling of Radiation Resistant, Locally Recurrent Prostate Cancer
Speaker: Neilsen, Beth, MD, PhD - Stanford University, Stanford, CA
4:45 PM - 4:55 PM PT

140 - Accelerated Partial Breast Irradiation (APBI) Delivered in Three Fractions is Safe and Efficacious: Preliminary Results from a Phase 2 Study
Speaker: Khan, Atif, MD, MS - Memorial Sloan Kettering Cancer Center, New York, NY
4:55 PM - 5:05 PM PT

141 - Preliminary Results of Hypofractionated Regional Nodal Radiation in Breast Cancer (HARVEST): A Randomized Non-Inferior Multi-Center Phase III Trial
Speaker: Xu, Fei-Fei, MD - Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai
5:05 PM - 5:15 PM PT

142 - Moderate Hypofractionated Radiotherapy for Regional Nodal Irradiation and Postmastectomy Radiation Therapy: A Systematic Review and Meta-Analysis
Speaker: Boelke, Edwin, MD - University of Duesseldorf, Haan, Nordrhein-
5:15 PM - 5:25 PM PT

143 - Accelerated Partial Breast Irradiation to 40 Gy in 10 Daily Fractions: Long-Term Results of a Phase II Study
Speaker: Lapen, Kaitlyn, MD - Memorial Sloan Kettering Cancer Center, New York, NY